News | March 26, 2015

SCAI Unveils Highlights for 2015 Scientific Sessions

Key topics will include emerging technologies, cardiac cath lab strategies and the latest clinical research

SCAI, 2015, Scientific Sessions, highlights, angiography

March 26, 2015 — The Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will take place May 6-9 in San Diego, California. SCAI 2015 will deliver updates affecting the invasive/interventional cardiovascular field, including late-breaking clinical trials; keynote addresses; and practice-relevant education for diagnosing and treating patients with congenital, coronary, peripheral and structural heart disease.

The SCAI 2015 keynote lecturers will include:

  • Peter J. Fitzgerald, M.D., Ph.D., and Christian Assad-Kottner, M.D., who will open the conference with a new session focused on how new and emerging technologies have the potential to transform every aspect of cardiovascular care. 
  • Robert Harrington, M.D., FSCAI, who will focus on the critical need for more clinical research in interventional cardiology, simplification of larger trials, better early-phase investigations and the use of electronic health records to ease the path to new research. His lecture, “The Future of Clinical Research in Interventional Cardiology: Challenges and Opportunities,” will be held Friday, May 8.
  • Joseph Loscalzo, M.D., Ph.D., sharing how advances in big data are helping to unlock some of the complexities of congenital heart disease, uncover the complex pathways that influence disease and providing the promise of new, personalized treatments. He will present his address, “Network Medicine:  A Systems Approach to Cardiovascular Disease Diagnosis and Management,” on Thursday, May 7.

SCAI 2015 will also feature –

  • SCAI’s Cath Lab Leadership Boot Camp, where cardiac cath lab teams will learn strategies for working collaboratively to deliver high-quality, appropriate care while reducing cost and improving resource utilization.
  • MOC Requirements & Controversies, where faculty and attendees will debate the role and maintenance of certification in interventional cardiologists’ lifelong learning.
  • How to Treat Critically Ill Patients, a pair of sessions focused on cardiogenic shock, including one offered jointly with the Heart Failure Society of America.


For more information:

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init